YALDOO LAITH L 4

What Happened
Yaldoo Laith L, reported as a 10% owner of Zivo Bioscience (ZIVO), made an open-market/private purchase of 1,543 shares on 2026-02-27 at $9.72 per share, for a total of $14,998. This was a purchase (P), which is generally viewed as a direct acquisition rather than a sale.

Key Details

• Transaction date: 2026-02-27
• Shares purchased: 1,543 at $9.72 each
• Total value: $14,998 (approx. $15k)
• Transaction code: P (Purchase; open market or private purchase)
• Form filed: 2026-03-03 — filed within the SEC’s typical 2-business-day reporting window for Form 4s
• Shares owned after transaction: Not disclosed in the provided filing excerpt
• No additional footnotes (e.g., 10b5-1 plan, tax withholding) were provided in the summary data

Context
As a reported 10% owner, Yaldoo Laith L is a significant shareholder (beneficial owner), not necessarily a company executive. Small purchases like this (~$15k) are factual signals of buying but are modest in size and should be weighed alongside other insider trades and company fundamentals. This filing appears timely and routine, providing transparent disclosure of the insider’s acquisition.